- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck in Belgium
Total 162 results
-
University Hospital, AntwerpAgentschap voor Innovatie door Wetenschap en TechnologieCompletedLocally Advanced Squamous Cell Carcinoma of the Head and Neck RegionBelgium, Netherlands
-
Hoffmann-La RocheTerminatedLocally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)United States, Korea, Republic of, Canada, Australia, Russian Federation, United Kingdom, Belgium, Brazil, China, France, Italy, Portugal, Spain, Japan, India, Thailand, Ukraine, Taiwan, Poland, Turkey, Hungary, South Africa, Germany
-
European Organisation for Research and Treatment...Merck KGaA, Darmstadt, GermanyRecruitingLocally Advanced Head and Neck Squamous Cell CarcinomaFrance, Belgium, Netherlands, Norway, United Kingdom, Ireland, Italy, Slovenia, Germany, Spain
-
AstraZenecaMedImmune LLCActive, not recruitingAdvanced Solid Tumors & Metastatic Squamous Cell Carcinoma of the Head and NeckSpain, United States, Belgium, Germany, United Kingdom, Italy
-
Incyte CorporationActive, not recruitingAdvanced Solid Tumors | Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Gastrointestinal (GI) MalignanciesUnited States, Netherlands, Spain, United Kingdom, Belgium, Austria
-
AstraZenecaRecruitingLocally Advanced Head and Neck Squamous Cell CarcinomaUnited States, Spain, Italy, Canada, Korea, Republic of, United Kingdom, Germany, Vietnam, Japan, France, India, Taiwan, Thailand, Malaysia, Turkey, Brazil, Belgium, Poland, Austria, Hungary
-
Cliniques universitaires Saint-Luc- Université...RecruitingSquamous Cell Carcinoma of the Head and NeckBelgium
-
NanobiotixRecruitingAged | Locally Advanced Head and Neck Squamous Cell CarcinomaFrance, Spain, Israel, United States, Taiwan, Finland, Japan, Belgium, Korea, Republic of, Hungary, China, Georgia, Portugal, Austria, Bulgaria, Canada, Czechia, Germany, Greece, Romania, Serbia
-
Cliniques universitaires Saint-Luc- Université...RecruitingSquamous Cell Carcinoma of the Head and NeckBelgium
-
GenmabCompletedHead and Neck CancerUnited Kingdom, Belgium, Slovakia, Hungary
-
Cliniques universitaires Saint-Luc- Université...TerminatedSquamous Cell Carcinoma of the Head and NeckBelgium
-
PfizerEMD Serono; Astellas Pharma Inc; Nektar TherapeuticsTerminatedSquamous Cell Carcinoma of the Head and Neck (SCCHN) | Metastatic Castration Resistant Prostate Cancer (mCRPC)Spain, United States, Poland, Belgium
-
Genentech, Inc.Completed
-
EMD SeronoCompletedSquamous Cell Carcinoma of the Head and Neck CancerCzech Republic, France, United Kingdom, Belgium, Hungary, United States, Poland, Slovakia
-
AmgenMerck Sharp & Dohme LLCCompletedCarcinoma of the Head and NeckUnited States, Canada, Switzerland, France, Spain, United Kingdom, Italy, Belgium, Austria, Australia, Greece
-
Universitaire Ziekenhuizen KU LeuvenAstraZeneca; European Organisation for Research and Treatment of Cancer - EORTC and other collaboratorsActive, not recruitingOral Cavity Squamous Cell CarcinomaBelgium
-
Cliniques universitaires Saint-Luc- Université...RecruitingOropharynx Squamous Cell Carcinoma | Oral Cavity Squamous Cell Carcinoma | Hypopharynx Squamous Cell Carcinoma | Larynx Squamous Cell CarcinomaBelgium
-
Cliniques universitaires Saint-Luc- Université...CompletedSquamous Cell Carcinoma of the Head and NeckBelgium, Luxembourg
-
European Organisation for Research and Treatment...Boehringer IngelheimCompletedCarcinoma, Squamous Cell of Head and NeckBelgium, Italy
-
Universitaire Ziekenhuizen KU LeuvenFlemish League Against CancerTerminatedHead and Neck CancerBelgium
-
Genentech, Inc.CompletedHead and Neck CancerUnited States, Germany, Spain, France, Australia, Hungary, Belgium, Bulgaria, United Kingdom, Italy, Romania
-
AstraZenecaPRA Health SciencesCompletedRecurrent/Metastatic Squamous Cell Carcinoma of Head & NeckUnited States, Canada, France, Spain, Belgium, Czechia, Korea, Republic of, Hungary, Malaysia, United Kingdom, Taiwan, Australia, Germany, Georgia, Israel
-
Jules Bordet InstituteInnate PharmaWithdrawnAdenocarcinoma of the Gastroesophageal Junction | Squamous Cell Carcinoma of the Esophagus | Adenocarcinoma of the EsophagusBelgium
-
AstraZenecaPRA Health SciencesCompletedRecurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and NeckUnited States, Belgium, Canada, France, Spain, Korea, Republic of, Hungary, Malaysia, United Kingdom, Taiwan, Germany, Georgia, Israel, Czechia
-
Centre Hospitalier Universitaire Dinant Godinne...Not yet recruitingHead and Neck Squamous Cell Carcinoma | Tumor GrowthBelgium
-
AstraZenecaCompletedSquamous Cell Carcinoma of the Head and NeckCroatia, Sweden, United States, Czech Republic, Italy, Russian Federation, South Africa, Spain, United Kingdom, Estonia, Latvia, Lithuania, Norway, Canada, Netherlands, Argentina, Belgium, Greece, Thailand, India, Israel, Malaysia, ... and more
-
Jules Bordet InstituteActive, not recruitingHead and Neck Squamous Cell CarcinomaBelgium
-
Merck KGaA, Darmstadt, GermanyCompletedHead and Neck CancerFrance, Russian Federation, Spain, United Kingdom, Germany, Hungary, Poland, Ukraine, Austria, Netherlands, Slovakia, Sweden, Switzerland, Belgium, Italy, Portugal, Czech Republic
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany; GORTEC (Head and Neck Oncology and Radiotherapy...Active, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States, Spain, Korea, Republic of, Taiwan, China, Argentina, France, Japan, Israel, United Kingdom, Belgium, Germany, Portugal, Greece, Italy, Georgia, Australia, Czechia, Brazil, Canada, Austria, Russian Federation, Switzerland and more
-
PfizerTerminatedSquamous Cell Carcinoma of the Head and NeckUnited States, Spain, China, Taiwan, France, Australia, Hungary, Korea, Republic of, Germany, Japan, Switzerland, Ireland, Israel, United Kingdom, Italy, Poland, Belgium, Canada, Greece, Portugal, Austria, Russian Federation
-
Incyte Biosciences International SàrlRecruitingHead and Neck CancerUnited States, Taiwan, Italy, Korea, Republic of, Spain, France, Portugal, Germany, Poland, Canada, Georgia, Greece, Netherlands, Belgium
-
AstraZenecaCompletedRecurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHNUnited States, France, Italy, Spain, Belgium, Czechia, Romania, Taiwan, Korea, Republic of, Brazil, Hungary, Japan, Russian Federation, Australia, Germany, Israel, Serbia, Bulgaria, Ukraine, Argentina, Poland, Chile, Croatia, Georgia
-
Bristol-Myers SquibbCompletedHead and Neck CancerUnited States, Brazil, Italy, South Africa, Spain, Canada, Argentina, Belgium, Chile, Czechia, Finland, France, Ireland, Mexico, Netherlands, Norway, Romania, Russian Federation, Sweden, Turkey, United Kingdom
-
Cliniques universitaires Saint-Luc- Université...CompletedSurgery | Head and Neck Squamous Cell Carcinoma | Growth FactorBelgium
-
European Organisation for Research and Treatment...Danish Head and Neck Cancer GroupActive, not recruitingLocally Advanced Head and Neck HPV Negative Squamous Cell CancersBelgium, France, Poland, Australia, Germany, Netherlands, Switzerland
-
University Hospital, GhentCompletedPrimary Non-operated Squamous Cell Carcinoma of Oral Cavity | Primary Non-operated Squamous Cell Carcinoma of Oropharynx | Primary Non-operated Squamous Cell Carcinoma of Hypopharynx | Primary Non-operated Squamous Cell Carcinoma of LarynxBelgium
-
University Hospital, GhentCompletedPrimary Non-operated Squamous Cell Carcinoma of Oral Cavity | Primary Non-operated Squamous Cell Carcinoma of Oropharynx | Primary Non-operated Squamous Cell Carcinoma of Hypopharynx | Primary Non-operated Squamous Cell Carcinoma of LarynxBelgium
-
AstraZenecaCompletedSquamous Cell Carcinoma of the Head and NeckUnited States, Canada, France, Italy, Spain, United Kingdom, Poland, Taiwan, Thailand, Vietnam, Belgium, Germany, Korea, Republic of, Brazil, India, Japan, Philippines, Russian Federation, Austria, Ukraine, Greece, Slovakia, Romania
-
Symphogen A/SCompletedCarcinoma, Squamous Cell of Head and NeckBelgium, France, Germany
-
Cliniques universitaires Saint-Luc- Université...University Hospital, Rouen; University Hospital, Montpellier; Central Hospital... and other collaboratorsUnknownAssessment of Regional Response With PET-FDG in Advanced Head and Neck Squamous Cell Carcinoma (pet)Head and Neck Squamous Cell CarcinomaBelgium
-
ALX Oncology Inc.Merck Sharp & Dohme LLCRecruitingHead and Neck Cancer | Head and Neck Squamous Cell CarcinomaUnited States, Belgium, Spain, Australia
-
Universitaire Ziekenhuizen KU LeuvenKU Leuven; Stichting tegen KankerRecruitingSquamous Cell Carcinoma of Head and NeckBelgium
-
IpsenTerminatedGastric Cancer | Colorectal Cancer | Bone Cancer | Squamous Cell Carcinoma of the Head and Neck | Advanced Cancer | Recurrent Disease | Pancreatic Ductal Adenocarcinoma | Metastatic TumoursUnited States, France, Belgium, Switzerland, Netherlands
-
AstraZenecaCompletedNeoplasms, Squamous CellUnited States, Czech Republic, Poland, Germany, Belgium, Taiwan, India, Serbia
-
AstraZenecaInnate PharmaActive, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States, France, Italy, Spain, Belgium, Canada, Taiwan, Switzerland, Korea, Republic of, Japan, Poland, Russian Federation, United Kingdom, Austria, Brazil, Germany, Netherlands, Portugal, Australia, Philippines, Bulgaria, G... and more
-
European Organisation for Research and Treatment...Active, not recruitingCarcinoma, Squamous Cell of Head and NeckFrance, Spain, Belgium, Italy, United Kingdom
-
Glycotope GmbHCompletedCetuGEX™ in Comparison to Cetuximab for the Treatment of Patients With Head and Neck Cancer (RESGEX)Carcinoma, Squamous Cell of Head and NeckBelgium, France, Germany, Italy, Poland, Romania, Spain
-
ALX Oncology Inc.Merck Sharp & Dohme LLCRecruitingHead and Neck Cancer | Head and Neck Squamous Cell CarcinomaUnited States, Korea, Republic of, United Kingdom, Spain, Belgium, Singapore, Canada, Netherlands, Australia
-
ExelixisRecruitingHead and Neck Squamous Cell CarcinomaUnited States, Belgium, Bulgaria, France, Italy, Korea, Republic of, Romania, Slovakia
-
AmgenTerminatedMelanoma | Cancer | Colorectal Cancer | Advanced Solid Tumors | Squamous Cell Carcinoma of the Head and Neck | Non-small Cell Lung Cancer | Oncology | Tumors | Advanced Malignancy | Oncology Patients | Transitional Cell Carinoma of BladderBelgium, France, United States, Germany, Australia